Here's What Key Metrics Tell Us About Aquestive Therapeutics (AQST) Q3 Earnings

For the quarter ended September 2025, Aquestive Therapeutics (AQST) reported revenue of $12.81 million, down 5.4% over the same period last year. EPS came in at -$0.14, compared to -$0.13 in the year-ago quarter.The reported revenue represents a surprise of -4.13% over the Zacks Consensus Estimate of $13.36 million. With the consensus EPS estimate being -$0.13, the EPS surprise was -7.69%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare ...